Table 2.
Comparisons of Response Rates between VTD4 and VTD6
| VTD4 | VTD6 | P-valuea | ||
|---|---|---|---|---|
| At 4 cycles | At 4 cycles | At 6 cycles | ||
| Pre-transplant response | ||||
| ≥Complete remission | 13 (10.1) | 6 (9.8) | 19 (31.1) | <0.001 |
| ≥Very good partial response | 103 (79.8) | 28 (45.9) | 41 (67.2) | 0.077 |
| ≥Partial response | 129 (100) | 61 (100) | 61 (100) | – |
| Post-transplant response at 3 months | ||||
| ≥Complete remission | 93 (72.1) | – | 38 (62.3) | 0.183 |
| ≥Very good partial response | 111 (86.0) | – | 51 (83.6) | 0.666 |
| ≥Partial response | 126 (97.7) | – | 54 (98.4) | 0.758 |
VTD4 indicates four cycles of bortezomib, thalidomide, and dexamethasone; VTD6 indicates six cycles of bortezomib, thalidomide, and dexamethasone
aComparison of pre-ASCT response rates